HilleVax
Boston
About HilleVax
HilleVax is a biopharmaceutical company that focuses on the development and commercialization of novel vaccines. HilleVax was founded in 2021 and was headquartered in Boston, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $235.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (Sep 2023)
- Ticker: nasdaq:HLVX
- Website: hillevax.com
- Phone: +1 (617) 213-5054
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/hillevax-3906 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.